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INTRODUCTION 
 
It’s never the fear of bringing a new life into the 
world that frightens a woman; it is the fear of the pain 
she has to endure to do it. 
 
The distress and agony which women endure during 
labour is immense and beyond description. The pain felt 
during labour increases in intensity along the course of 
labour. As reported on the Mc Gill pain questionnaire 
labour pain is one of the most intense pains a woman can 
expect.   A study of women in the first stage of labour 
reported that 60% of primiparous women described the 
pain of uterine contractions as being “unbearable, 
intolerable, extremely severe and excruciating”. 
      
Many factors have an effect on the degree of pain 
experienced by woman during labour including 
psychological preparation, emotional support during 
labour, past experiences, patient expectation of birthing 
procedure and augmentation of labour with oxytocin. 
Read et al in 1944 suggested that labour pain is in large 
measure due to emotional stress. 
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Programmed labour is a protocol developed by 
researchers over a period of a decade.  It incorporates 
the principles of  “ Active management of labour ”, with 
systemic administration of drugs for pain relief.  The 
concept of ‘Active management of labour” was first 
advanced by Professor O”Driscoll, Studd, Philpotts and 
Castle.  The key elements in addition to strict diagnostic 
criteria for labour are early amniotomy, use of oxytocics 
to optimize pain, judicious use of analgesics and 
continuous professional support.     
  
Synergistic application of analgesics and 
antispasmodics during the active phase of labour curtails 
prolonged labour and provides a more comfortable and 
relatively pain free labour experience for the mother.  
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AIMS OF STUDY 
 
The  study was done to assess the safety and 
efficacy of programmed labour protocol. The aims of 
the study were 
  
1. To study the degree of analgesia during the period 
of labour. 
 
2. To assess the effect of programmed labour on the 
duration of labour.  
 
3. To assess the effect of programming labour on 
neonates. 
 
4. To assess adverse effects of programmed labour, if 
any, immediate or delayed on maternal and foetal 
well-being. 
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PAIN PATHWAY 
 
Pain in the first stage of labour is generated largely 
from uterus and is visceral in nature.  Sympathetic 
visceral afferents transmit sensation of pain from the 
uterus, cervix and upper vagina through the 
Frakenhauser ganglion, the pelvic plexus, the middle and 
superior internal iliac plexus into the spinal cord through 
white rami communicantes associated with T10, T11, T12 
and L1.  Early in the first stage of labour, pain of uterine 
contractions is transmitted predominantly through 
eleventh and twelfth thoracic nerves. 
 
Pain with vaginal delivery is somatic pain arising 
from stimuli from the lower genital tract.  These are 
transmitted primarily through the pudendal nerve ( S 2, 
3, 4 ) which provides sensory innervation to the 
perineum anus and more medial  parts of the vulva and 
clitoris. 
 
Opinions regarding pain relief during labour invite 
divergent and widely polarised views.  There are 
protagonists of the “laissez faire” policy of leaving things 
to nature but the distress felt by labouring women is so 
intense that there is a definite role for labour analgesia.  
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ROLE OF PAIN RELIEF 
 
Labour pains may be aggravated by anxiety, fear, 
maternal expectations and the mother’s state of 
preparation for delivery. As with other forms of visceral 
pain labour pain stimulates an intense and complex 
autonomic response. It increases maternal oxygen 
consumption, cardiac output and circulating 
catecholamines (Schnider et al 1983). The rise in serum 
catecholamines may cause fetal tachycardia or 
bradycardia and dysfunctional uterine contractions.  
Freedom from pain improves the environment for both 
mother and foetus and thereby improves obstetric 
outcome. 
 
For the mother, obstetric analgesia provides relief 
from pain controls alterations in circulation, ventilation 
and undue muscular efforts.  It ensures better patient 
cooperation.   
 
For the foetus, labour analgesia means shorter and 
less traumatic labours, protection against hypoxia and 
foetal depression at birth, and protection against 
needless instrumental assisted delivery necessitated by 
maternal distress.   
 
To the obstetrician, it provides a better control of 
events emerging the course of labour reduces pressures 
from the patients and relatives to intervene and ensures 
optimum condition to prevail at the time of childbirth. 
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Since time immemorial there have been attempts to 
reduce the suffering of the labouring woman and from 
this has evolved several methods of alleviating pain 
during labour 
 
Non Pharmacological methods for pain relief during 
labour 
These are said to support the natural physiological 
responses to labour pain, the gate mechanism of pain 
control and the release of endogenous opioids. (Melzack 
& Wall 1964) 
 
1.  Relaxation / Breathing Techniques / Massage 
These forms of pain relief can allay anxiety, 
encourage relaxation, provide a focus of distraction 
from pain and tension and encourage a positive 
attitude.  
 
2.  Positioning and Movement 
Mobility and the adoption of a position of 
comfort will be advantageous to the woman. An 
upright or kneeling position is said to improve the 
dimensions of the pelvis and encourage forward 
rotation of the fetus. This may lead to a decrease in 
the use of regional anaesthesia and analgesics.  
 
3. Temperature Modulation: Hot or Cold packs, Hot 
or Cold water 
Hot packs to the abdomen and back or the 
perineum in the second stage of labour have the 
 13
potential to relieve the burning sensation of pain. 
For some women the use of extreme cold may be 
similarly useful. 
 
Hot baths or showers produce a number of 
beneficial effects including relaxation and increased 
well-being.  
 
A reduction in pain perception occurs as a 
result of the stimulation of tactile and thermal 
receptors by warm water. The response to this is to 
reduce pain stimulus at the dorsal column “closing 
the gate” to pain.  
 
4.  Transcutaneous Electrical Nerve Stimulation 
(TENS) 
Is thought to work by interrupting pain 
transmission along the sensory pathway and by 
stimulating endogenous opioids. 
 
Commonly two electrodes are adhered 
vertically over the woman’s back parallel to her 
spine between the areas of T10 down to S4.  
 
The electric current used may be of low 
frequency and intermittent, or high frequency and 
continuous.  
 
Low frequency TENS stimulates the release of 
endogenous opioids while the high frequency current 
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closes the pain gate. The sensation experienced may 
be felt as a tingling or as a sharper electric shock 
sensation. The current can be modified during use  
 
5.  Acupuncture 
A form of Eastern medicine said to relate to the 
flow of energy called Qi within the body where 
needles are inserted along specific pathways or 
“meridians”. 
 
Its action may be related to stimulating the 
release of endogenous opioids as well as the 
transmission of pain stimuli.  
 
Acupressure and Reflexology utilize similar, but 
distinct techniques.  
 
6.  Herbalism and Aromatherapy 
These make use of natural plant extracts or 
essential oils. 
 
These remedies may improve physiological 
balance, strength and stamina within the mind and 
body.  
 
Knowledge of specific usage is important, as 
the use of some of these remedies is contra-
indicated in pregnancy and labour, while others may 
have an adverse effect on the baby if it comes in 
direct contact with them.  
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7.  Hypnosis 
Self-hypnosis and post-hypnotic suggestion can 
provide an effective form of pain control for suitable 
subjects. 
 
8.  Intradermal Injection 
Provide relief of pain and backache by injecting 
sterile water (0.1-0.5 mls) intradermally, to the 
lower sacral region 
 
 
Pharmacological methods for pain relief during 
labour 
1.  Systemic Analgesia 
Parenteral administration of opiods and 
sedative hypnotics are a commonly used method of 
analgesia.   Opiod receptors located in cardiac atria 
are activated by circulating opiods to excite vagal 
afferents.  These in turn activate descending nerve 
fibres that are inhibitory to pain stimuli thus 
decreasing the sensation of noxious stimuli.  In 
effect IV opiods produce spinal analgesia without 
spinal injection. 
 
2. Intravenous PCA. 
The use of an intravenous PCA may be of use 
for women where the placement of an epidural is 
contraindicated. The total drug requirement to 
achieve adequate pain relief is usually less using 
this method than with intramuscular narcotics or a 
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continuous intravenous infusion. Fentanyl 
(10mcg/ml) is the drug of choice.  
 
3.  Inhalation analgesia. 
Nitrous Oxide is used. This is a colourless, 
odourless gas. Used in higher concentrations it can 
provide effective pain relief, with the advantage that 
it’s effects are short lived, and there is minimal 
complications in the neonate. It is obtained by the 
woman’s own respiratory effort via a piped supply. 
 
Analgesia is obtained within 20- 30 seconds of 
commencement and maximum effect is felt after 
about 45 seconds.  
 
The use of this form of pain relief is rarely 
contraindicated.  
 
Self-administration is the recommended 
method for use as the patient drops the mask/ 
mouthpiece if she absorbs too much of the gas.  
 
4.  Epidural Analgesia. 
Epidural analgesia can provide an effective 
form of pain relief in labour. It may be beneficial for 
women having a long or painful labour, be required 
on the grounds of fetal benefit, or administered for 
maternal or obstetric indications. It may also be 
provided at maternal request 
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There are some medical contraindications to its 
administration.  
 
Complications include hypotension, headache, 
dural tap and a “patchy” block. Other issues relate 
to the reduction of motor function and sensation in 
the woman’s legs and impaired bladder function.  
 
The use of low dose (ropivicaine/ fentanyl) 
patient controlled epidural analgesia (PCEA) reduces 
a number of the side effects experienced by the 
mother, retains the urge to push for the majority of 
women and reduces the likelihood of an assisted 
vaginal delivery.  
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REVIEW OF LITERATURE 
 
A study of literature reveals that there have been 
various attempts to relieve the labouring woman of her 
suffering, through various methods, which includes 
administration of systemic analgesia. 
 
There have been studies on the efficacy of opioid 
analgesics- tramadol, pentazocine, pethidine, the use of 
diazepam, and the role of ketamine each used 
individually or in combination with other drugs. 
 
1. S.N. Daftary et al based on their study on 
500 low risk primigravida’s concluded that 
programmed labour protocol shortens 
duration of labour facilitates cervical 
dilatation, reduces pain during labour and 
improves maternal and neonatal outcome and 
decreases need for obstetric interventions. 
 
2. Chauhan et al conducted a clinical study of 
programmed labour.  Their observation was 
that programmed labour accelerated the 
normal course of labour and provided pain 
relief with no adverse effects on the neonate. 
 
3. Hema Diwakar, Patel concluded after a 
adopting programmed labour protocol on low 
risk parturients that duration of labour was 
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much curtailed, obstetric interventions did 
not increase and neonatal outcome was 
satisfactory. 
 
4. Dixit et al in Fogsi Focus 2005 on Indian 
experiences in programmed labour based on 
their study concluded that duration of labour 
is shortened and there is improved maternal 
and neonatal outcome  
 
5. Cochrane Review by Elbourne D, Wiseman RA, 
1998 showed that there was no evidence of a 
difference between pethidine and tramadol in 
terms of pain relief, interval to delivery, or 
instrumental or operative delivery. There 
appeared to be more adverse effects such as 
nausea and vomiting and drowsiness with 
pethidine when compared to Tramadol. 
Maternal satisfaction with pain relief 
appeared similar for pentazocine and 
pethidine, with more frequent nausea and 
vomiting with pethidine 
 
6. Erskine WA et al 1985 in a comparative study 
between pentazocine and pethidine in self-
administered intravenous analgesia during 
labour concluded that good analgesia was 
obtained with both drugs, with pentazocine 
having a decided advantage over pethidine 
because of its lack of side effects. 
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7. Wahab SA et al 1988 studied the effect of 
some recent analgesics- pentazocine, 
nalbuphine and butarphanol on labor pain and 
maternal and fetal blood gases and pH. They 
reported that the studied analgesics caused 
significant maternal respiratory acidosis and 
fetal metabolic acidosis. These acidotic 
changes were most marked with pentazocine, 
moderate with nalbuphine and minimal with 
butarphanol. 
 
 
8. Bitsch M et al 1980 concluded that no adverse 
side effects were observed with Tramadol 
concerning the follow-up of labour or the 
newborn. Tramadol can be recommended for 
obstetrical analgesia since it does not exert 
inhibitory effects upon the respiratory center. 
 
9. Viegas OA et al 1993 stated that Tramadol 
100 mg is as effective as pethidine 75 mg but 
has a superior safety profile 
 
10. Lewis KS, et al 1997 concluded that for for 
labor pain, i.m. Tramadol works as well as 
meperidine and is less likely to cause 
neonatal respiratory depression 
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11. Husslein P et al 1987 conducted a prospective 
randomized comparative study on Obstetrical 
analgesia with tramadol-- Based on their 
study they established that established an 
analgesic effect of tramadol similar to 
pethidine but with less side effects. 
 
12.  Jain S. et al based on their study on 
Analgesic efficacy of Intramuscular opioids 
versus epidural analgesia in labor, concluded 
that the analgesic efficacy and maternal 
satisfaction is better with epidural analgesia 
than with opioids. Analgesia provided by 
meperidine and tramadol is comparable and 
approximately 50% of women rated the 
analgesia as good. Hence in developing 
nations where availability of facilities is the 
main limiting factor, Intramuscular opioids 
can be considered suitable alternatives. 
 
13. Fieni S, et al concluded that Tramadol in 
accordance to the obtained data from their 
study  - Evaluation of the peripartum effects 
of 2 analgesics: meperidine and tramadol, 
gives an analogous analgesic effect, with 
better tolerability for the absence of 
collateral effects on the mother, fetus and 
newborn. 
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14. Arkatov VA, et al, In their study (The effect 
of tramadol and acupuncture analgesia on 
labor pain and the psycho emotional status of 
the parturient] concluded that while tramadol 
(at a dose of 1.43 +/- 0.06 mg/kg) was 
optimal during "programmed" delivery, 
acupunctural analgesia was optimal during 
delivery without any correcting therapy. 
 
15. Neumark J, Schmid E. 1978 in their study 
stated that 80% patients administered had 
complete amnesia for the time of delivery, 
but most of them remained cooperative, 
nevertheless. The main advantage of this 
technique lies in keeping most of the 
parturients cooperative and able to help with 
pushing, while offering them amnesia and 
analgesia for this period. 
 
16. Youssef AR et al. 1978.concluded that 
excellent analgesia was achieved with 
ketamine, however hallucinations were 
troublesome. There were no untoward effects 
on fetuses. 
 
17. Avangade O. 1978 concluded that carefully 
controlled intravenous administration of 
ketamine produced excellent analgesia and 
dissociative sleep in all patients in the active 
phase of labor. The introduction to delivery 
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interval was significantly shortened. Of the 
50 patients studied, 49 were unable to 
remember if contractions were painful and 
80% experienced and narrated dreams. The 
auditory component was consistently intact in 
82% of the cases; 78% described the total 
experience as pleasant, while the rest found 
it unpleasant or uncertain. The one-minute 
Apgar score of 6.8 was not significantly 
different from that of the general population. 
 
18. Altissimi C. 1979 stated the drug's 
(ketamine) absolute non-toxicity (as observed 
in quoted experimental studies) together with 
the labour response and effects on the foetus 
and mother (tested in most cases with 
cardiotocography and haemo gas analysis) 
suggest that ketamine is useful in obstetric 
analgesia.  
 
19. Amano K et al 1981 concluded that there was 
Loss of long term variability was persistently 
noted until the end of labor from 20-40 min. 
after the administration of Diazepam and 
Pentazocine, however there was no significant 
different of blood gas and acid-base balance. 
 
20. Leuxner  E. & Thomas J. Munch. Med. Wachr.  
94 564(1952) reported satisfactory results 
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with Hoyscine Butyl bromide as a means of 
shortening first stage of labour.  
 
21. Tateiwa T. Italura K., Nowa K. in Clin. Rep. 7, 
1249-1254 observed the influence of 
Buscopan suppository on delivery and found 
that it hastened parturition when 
administered in pregnant women in the first 
stage of labour when the uterocervical mouth 
is beginning to be widened. 
 
22. G. Corssen (Med. Klin 48 1286 – 1288) 
studied the use of Buscopan in 112 patients 
in labour and concluded that Buscopan is of 
particular value in relieving cervical spasm 
and thus promoting cervical dilatation.  No 
untoward side effects on the mother and child 
were observed.  
 
23. Prof. S. Samal Uma Gupta in a study of 150 
primigravidas in labour conducted at Mahatma 
Gandhi Institute of Medical Sciences, 
Sevagram concluded that Hyoscine Butyl 
bromide shortened the mean duration of 
labour on an average by two hours forty two 
minutes with no side effects on fetus or new 
born.   
 
24. P. Bhattacharya & S.G. Joshi in a study of  
“Acceleration of labour – Intramuscular  
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Buscopan injection” by using 200 
primigravidae – 100 as cases and 100 as 
control – concluded that Buscopan is a 
parasympatholytic agent and shortens the 
first stage of labour by accelerating the 
cervical dilatation.  Mean labour time in 
Buscopan was 5 hours 13 minutes where as in 
control group it was 8 hours and 50 minutes.   
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PROGRAMMED LABOUR 
 
In an attempt to relieve pain, in the past analgesics, 
sedatives, narcotics and smooth muscle relaxing drugs 
have been effectively used.  It was uniformly observed 
that these drugs relieved pain considerably, and 
shortened the duration of labours, however, if the foetus 
was born very easily, it often suffered from side effects 
of the drugs causing respiratory depression at birth and 
asphyxia in the new born.   
 
The key element in programmed labour is that drugs 
are administered in controlled doses in a programmed 
fashion and at appropriate times to avail the benefits of 
drug synergism while limiting the usage of drugs within 
safety limits so as to avoid maternal and foetal jeopardy 
 
Programmed labour is a protocol developed by 
researchers over a period of a decade. It is based on the 
incorporation of the three principles of active labour. 
 Synergistic application of analgesics and 
antispasmodics during active phase of labour 
 Plotting of patients partogram  
 To adopt timely intervention to optimise labour 
outcome 
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Pharmacology  of drugs used in programmed labour 
 
 
Factors determining safety of analgesic used for 
labour analgesia 
 Route 
 Physical and Chemical properties 
 Placental transfer 
 Foetal distribution 
 
Route 
The drug can be given by either of these routes – 
oral/ im / iv / sc 
 
Physical and Chemical properties 
Analgesics penetrate body cells by passing through 
cell membranes, which is a lipid bilayer.  Drug 
penetration by determined by lipid solubility of the drug.  
Aromatic ring containing drugs and unionised form of 
drugs are highly permeable.  Opioids are weak bases 
coexisting as undissociated freebase and dissociated 
cations.   
 
Placental transfer 
Placental transfer is determined by the following 
factors: 
1. Maternal blood concentration of the drug 
2. Concentration of free drug in maternal plasma 
3. Maternal metabolism and renal excretion of the 
drug 
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4. Lipid solubility 
5. Placental metabolism 
6. Molecular weight of drug 
7. pH of blood on both sides of placenta 
8. Differential blood flow on either side of 
placenta 
 
Uteroplacental flow reduction occurs during 
spontaneous labour, use of oxytocin, aortocaval 
compression, PIH, Diabetes.  Venous obstruction 
increases the interval over which drug comes in contact 
with diffusion membranes and facilitates drug transfer to 
foetus. 
 
Uptake of drug is reduced if foetal cardiac output is 
reduced. 
 
PH of blood on foetal side is normally 0.1 – 0.2 
units lower.  Therefore more of drug remains in ionised 
state on the foetal side.  Because maternal and foetal 
equilibrium is established only for unionised form of drug 
Æresults in greater total ionised and unionised drug load 
in the foetus. 
Foetal distribution;  
Placental blood is a mixture of blood in intervillous 
spaces and fresh blood coming from foetus for removal of 
CO2 and waste products of metabolism.  Drugs 
transferred from maternal to foetal compartment are 
diluted before distribution to various foetal organs. In 
IVC drug is diluted by blood coming from lower 
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extremities abdominal viscera upper extremities and 
thorax.  Amount of drug ultimately reaching vital organs 
depends on blood flow to the organ.  Since CNS is highly 
vascular it receives greater amount of drug.   
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DIAZEPAM 
 
Diazepam is a long lasting highly lipophilic 
benzodiazepine.  In obstetrics IV diazepam has gained 
popularity because of its calming-analgesic properties 
and relative safety.  
 
Pharmokinetics 
Diazepam undergoes oxidation reduction (Phase I) 
reaction in the liver.  It forms two active metabolites 
desmethyldiazepam and oxazepam hence resulting in 
increased elimination half-life. 
 
Clearance of diazepam is 0.2 – 0.5 ml per kg per 
minute. 
 
Increased age reduces clearance of diazepam. Also 
in obese individuals volume of distribution is increased as 
drug goes from plasma into adipose tissue.  Elimination 
of t ½ is prolonged in obese patients because of delayed 
return of drug to plasma  
 
Mechanism of action 
Diazepam exerts general effects by occupying BZD 
receptors that modulate GABA, the major inhibitory 
neurotransmitter in the brain.  It has rapid onset of 
action – usually within 30 – 60 seconds.  It has relatively 
shorter duration of action because of rapid redistribution. 
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Effect on CNS 
  When given IV, though some degree of awareness is 
maintained patient has anterograde amnesia 
(interference of establishment of memory trace), the 
patient does not recollect events on recovery. 
 
Effect on RS 
Diazepam is known to cause respiratory depression 
especially so when used along with opioids.  Peak 
decrease in minute ventilation occurs at doses of 0.3 mg 
per kg 
 
Effect on CVS 
Diazepam has modest hemodynamic effects.  There 
might be a slight decrease in arterial BP.   
 
Side effects  
Diazepam is remarkably a safe drug with high 
margin of safety.  It is free of allergenic effects.  Major 
side effect is respiratory depression.  Venous irritation 
and thrombophlebitis occurs which is related to its 
aqueous insolubility.    Amnesia and sedation occur which 
last for longer than period of unresponsiveness 
 
Foetal side effects include hypotonicity, decreased 
activity, respiratory depression, impaired temperature 
regulation and decreased response to metabolic stress 
(McAllister – 1980). 
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DIAZEPAM
 33
KETAMINE 
 
Ketamine is a phencyclidine derivative. It is N – 
methyl D – aspartate NMDA receptor agonist that 
produces dissociative anaesthesia and has been used in 
pregnant patients.  It exists as to isomers of which S-(+) 
isomer is more potent.  It has significant analgesic effect 
and does not usually depress the cardio vascular or 
respiratory system.  But it does posses some of the 
worrisome adverse psychological effects found with other 
phencyclidines. 
 
Mechanism of action 
Its mechanism of action is mediated by an 
interaction with phencyclidine receptors located in the 
limbic and corticothalamic areas of the brain. 
 
Pharmacokinetics 
Ketamine is highly lipid soluble and of note is its 
rapid distribution.  It has a large volume of distribution 
and clearance is also high which is why it has short 
elimination t½ of 2 – 3 hours.  Peak onset of action after 
IV bolus is 30 – 60 sec.  Changes in liver blood flow 
affect clearance.   
 
Effects on CNS 
Ketamine produces dose related unconsciousness 
and analgesia.  It causes the blood brain barrier within 
30 seconds of administration.  Its maximal effect in one 
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minute. It starts acting with in a minute and recovery 
starts after 10/15 minutes.  But patient remains amnesic 
for 1-2 hours.  Emergence delirium, hallucination and 
involuntary movements occur in up to 50% of patients.  
Other undesirable side effects include a 40% rise in 
uterine tone when ketamine is used in larger doses. (1.5 
–2.0 mg/kg) Muscle tone increases. 
 
Duration of ketamine anaesthesia after single 
administration is for 10-15minutes and patient gains full 
orientation to person, place and time within 15 – 30 
minutes.  It induces a so-called “dissociative 
anaesthesia” – profound analgesia, immobility, amnesia 
with light sleep and a feeling of dissociation from one’s 
own body and surroundings. The onset and duration of 
analgesia is rapid, intense and prolonged.  
 
Effects on RS 
Ketamine has minimal effect on central respiration.  
Respiration is not depressed and reflexes are not 
abolished.  It also acts as bronchial smooth muscle 
relaxant. 
 
Effects on CVS 
Ketamine stimulates cardio vascular system.  Heart 
rate, cardiac output , BP are elevated due to sympathetic 
stimulation. It should therefore not be used in patients 
with pregnancy induced hypertension 
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Effect on Foetus 
Although, ketamine crosses over into the foetal 
circulation, it is rapidly metabolised and does not depress 
the respiratory centre. High doses cause increased 
uterine tone This has shown to produce neonates with 
lower Apgar scores, respiratory depression and hypotonia 
(Akamatsu et al 1974) 
 
Role in labour analgesia 
The main advantage of using this drug lies in 
keeping most of the parturients cooperative and able to 
help with pushing, while offering them amnesia and 
analgesia for this period  (Neumark Schmid E.) 
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KETAMINE
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OPIOIDS IN OBSTETRIC ANALGESIA 
 
Opioids are the most commonly used class of drugs 
for systemic analgesia in laboring women.  The opioids 
used in programmed labour are pentazocine and 
tramadol.  
 
Mechanism of action 
Nociception due to uterine and cervical distension 
could be suppressed by mu and kappa receptors agonists 
in rats.    
 
Pharmacokinetics 
 
Effect on CNS. 
 Opoids are strong analgesics. Dull poorly localised 
visceral pain is relieved better. Associated reaction to 
intense pain (apprehension, fear, autonomic effects) are 
also depressed. It has a calming effect. 
 
Effects on CVS 
 Therapeutic doses cause little in blood pressure of 
recumbent normotensive patients. Postural hypotension 
and fainting however can occur due to impairment of 
vascular reflexes. 
 
Effects on RS 
 Morphine depresses the respiratory centre in a dose 
dependent manner.  
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Effect on uterine contractions 
 During the latent phase - it inhibits contractions 
 During active phase – increases frequency 
duration and amplitude of contractions. 
 
Effect on the fetus 
FHR shows decrease in short and long term heart 
rate variability due to depression of fetal CNS or direct 
effect on fetal myocardium. Diminished FHR variability 
occurs regularly following meperidine administration and 
duration of effect is related to route of administration. 
Opiods can decrease neonatal minute volume, lower 
oxygen saturation. Neonate is less able to tolerate 
narcotic induced depression and hypoxia and respiratory 
acidosis may ensue rapidly. 
 
Opiods given to the mother during final hour before 
delivery or more than six hours before delivery are less 
likely to have a depressive effect upon the neonate. 
 
Pentazocine: 
Pentazocine is opioid agonist antagonist.  Analgesia 
produced by pentazocine is related kappa receptor 
stimulation. It is ¼ - ½ as potent as morphine. 
 
It produces less nausea and postural hypertension 
than other opiods but is reported to produce increased 
incidence of dysphoric reactions than other 
agonists/antagonists. 
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Tramadol 
Tramadol is a synthetic derivative. It is a 4-phenyl 
biperidine analogue of codeine. 
 
It stimulates mu receptors and to a lesser extent 
the delta and kappa opioid receptors. It is 1/5 – 1/10 as 
potent as morphine. Tramadol activates only 30% of 
opioid receptors as tested by naloxone antagonists. 
 
Like tricyclic antidepressants it also activates spinal 
inhibition of pain by decreasing the reuptake of 
norepinephrine and serotonin. This contributes to 70% of 
nociception provided by Tramadol.  
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TRAMADOL
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CH CH = C(CH )2 3 2
PENTAZOCINE
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HYOSCINE N – BUTYL BROMIDE  
(BUSCOPAN) 
 
It is a quaternary ammonium derivative of 
scopolamine 
 
Mechanism of action 
Acts primarily by blocking the transmission of neural 
impulses in the intramural parasympathetic ganglia of 
abdominal organs apparently by inhibiting the cholinergic 
receptors. Peripheral anticholinergic action results from a 
ganglion blocking action within the visceral wall as well 
as from the anticholinergic activity 
 
Pharmacokinetics 
Onset of action 2-3 minutes following IV 
administration. Does not cross the blood brain barrier 
concentrates in tissues of GI tract and kidneys 
 
Role in labour 
Acts as a smooth muscle relaxant in cervical 
dilatation.  Selectively blocks the cervicouterine plexus 
and brings about dilatation of the cervix. 
 
Side Effects 
Dryness of mouth, visual disturbances, tachycardia, 
dizziness – mild and self-limiting.  Allergenic reactions 
are rare. 
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MATERIALS AND METHODS 
 
The Study was conducted at Government Rajaji 
Hospital, Madurai on 50 selected low risk pregnant 
women who had received adequate antenatal care and in 
whom the gestation maturity is well documented.   
 
Case selection for painless vaginal delivery was 
done in consultation with anaesthetist. Informed consent 
was obtained from each parturient in study group. 
Control group was not given any intervention and was 
well matched with study group in age, parity and labour 
characteristics.    
 
INCLUSION CRITERIA 
The following criteria where applied prior to 
including the case in the study. 
1. Primigravida or multigravida between 21 to 35 
years of age. 
2. No known obstetric or medical complication 
present. 
3. Haemoglobin status more than 10.5 gram 
percent 
4. Gestational maturity between 37 to 41 weeks 
5. No clinical evidence of cephalopelvic 
disproportion 
6. No other contra indication to vaginal delivery 
(eg. Placenta praevia) 
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EXCLUSION CRITERIA 
Antenatal women with the following were excluded 
from the study 
1. PIH 
2. Heart Disease complicating pregnancy 
3. Diabetes and jaundice 
4. History of taking medications like tricyclic 
antidepressants, MAO inhibitors, sedatives or 
hypnotics 
5. Mal presentation 
6. Post caesarean pregnancy 
7. Multiple pregnancy 
8. Existing foetal distress 
 
Cases were selected after complete history was 
taken.  Vital parameter and weight of the patient was 
recorded.  Basic investigations, which included Urine for 
albumin, sugar, Blood Hb%, and Blood grouping and 
typing. Pelvic assessment to rule out CPD was done and 
patients with borderline and definite CPD were excluded 
from the study. 
 
The following parameters were monitored: 
 Progress of labour with partogram 
 Maternal well being 
 Foetal well being 
 Development of side effects 
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Progress of Labour 
The progress of labour was monitored by 
partographic recording. The frequency and duration of 
uterine contraction was noted by abdominal palpation. 
Cervical dilation and descent of foetal head were 
assessed by per vaginal examination every one hour. 
 
Maternal well being 
The maternal condition was assessed by careful 
supervision of hourly BP, respiratory rate every 30 
minutes, pulse rate every 30 minutes. 
 
Foetal well being 
The foetal condition was monitored by noting the 
FHR every 15 minutes, colour of liquor after ARM done at 
on set of active phase of labour, presence of 
caput/moulding and Apgar scores at 1 minute and 5 
minutes after birth of baby. 
 
Development of side effects 
The following side effects were well looked out for 
 Tachycardia                      
 Rise of Blood Pressure 
 Fall of Blood Pressure 
 Nausea/vomiting 
 Pyrexia 
 Hallucinations 
 Amnesia 
 Post partum haemorrhage 
 Vaginal tears/lacerations 
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 Cervical tears 
 Post partum psychosis 
 
Continuous verbal communication to assess pain 
relief was done for every patient included in the study. 
 
 
PROGRAMMED LABOUR – PROTOCOL 
The protocol of Programmed Labour that I have 
studied and followed has been developed indigenously by 
Dr. Daftary and team at the Nowrosji Wadia Maternity 
Hospital in Mumbai and extensively evaluated in the 
country. 
 
Programming of Labour was done in the following 
manner 
 I/V line was established with 500ml of ringer 
lactate solution 
 
 Patients should be getting at least 2 to 3 
sustained contractions/10 minutes; if the pains 
were ineffective oxytocin infusion was started. 
 
 At cervical effacement of 75% and more and 
dilatation of 3 cms and above administer 6.0 
mg pentazocine along with 2.0 mg diazepam 
given as IV bolus through infusion line (this is 
prepared by diluting 1 ampoule of diazepam –
10 mg and 1 ampoule of pentazocine – 30 mg 
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in 10 ml of normal saline and administering 2 
ml of this solution slow IV). 
 
 Administer Inj. Tramadol 50.0mg 
Intramuscularly.  Patients weighing more than 
60 kgs, the dose of Tramadol is increased to 1 
mg per kg body weight. 
 
 Administer Inj. Buscopan intramuscularly along 
with Tramadol.  This may be repeated after 
four hours if necessary. 
 
 Monitor patient’s vital signs and FHR. 
 
 Some patients who have been relatively 
comfortable so far may complain unbearable 
pains when the head reaches the pelvic floor 
and causes stretching of pelvic floor muscles 
and cervix has dilated to 7 cms or more.  In 
such patients Ketamine was given at a dose of 
0.5-mg/kg body weight as IV bolus.  Top of 
doses are given at a dose of 0.25 mg per kg 
body weight are repeated at an interval of 20 
to 30 minutes until delivery if required.   
 
 Local infiltration anaesthesia was given for 
those patients requiring episiotomy. 
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 Inj. Methergine 0.4 mg. IV after delivery of 
anterior shoulder for active management of 
third stage of labour. 
 
 New born was checked by neonatologist at 
birth and the Apgar scores at 1 minute and 5 
minutes were recorded.  The birth weight and 
any other relevant findings documented.   
 
 Add 10 mg Diazepam to the IV infusion given 
slowly over two hours.  This prevents emerging 
hallucinogenic reactions in case ketamine has 
been used.   
 
 The extent of pain relief experienced by the 
patients and also the degree of amnesia was 
documented. The pain relief was documented 
as below. 
 
Score – 0 – no relief from pain. 
Score – 1 - (Mild) some relief from pain. 
Score – 2 – (Moderate) substantial relief from  
   pain. 
  Score – 3 – (Excellent) almost complete relief. 
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OBSERVATIONS AND RESULTS 
 
 
This study was conducted on 50 low risk antenatal 
patients in whom drugs for programming of labour were 
introduced at the onset of active phase of labour. 
 
Similar low risk counterparts were taken for 
controls. 
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Table 1 
Distribution of cases according to age group 
 
Study Control Age group 
No. % No. % 
15  -  20 8 16 7 14 
21  -  25 28 56 27 54 
26  -  30 14 28 16 32 
Mean 23.7 yrs 24.0 yrs 
Standard 
deviation 
2.8 3.0 
 
‘p’ = 0.586 
On analysis of study group age wise, the 
primigravida age group ranged from 18 years to 29 years 
and the multigravida age group distribution was 20 –30 
years. The mean age of the study group was 23.7 years. 
In the control group, the primigravida age ranged 
from 18 –29 mean and multigravidas ranged from 20 to 
30 years. The mean age of the control group was 24 
years. 
There was no significant difference of age in both 
groups. (p>0.05) 
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Table 2 
 
Booking status 
 
Study Control 
 
No. % No. % 
Booked 35 pts  (70%) 30 pts  (60%) 
Unbooked 15 pts  (30%) 20 pts  (40%) 
 
‘p’=0.4017 (not significant) 
 
Booked and unbooked cases were distributed evenly 
in both groups.  However all patients chosen had a 
minimum of two antenatal check ups in the 3rd trimester. 
 
 
 
 
 54
Booking status 
0 10 20 30 40
Study
Control
Unbooked
Booked
 55
Table 3 
 
Distribution of cases according to residence 
 
Study Control 
 
No % No % 
Rural 34 pts 68  32 pts 64 
Urban 16 pts 32  18 pts 36 
 
 
In the study 34 patients (68%) are from rural areas 
and 16(32%) patients from urban areas. In the control 
group 32 (64%) patients are from rural areas and 18(36) 
patients are from urban areas. In both the study and the 
control groups majority are from rural areas. 
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Table 4 
 
Type of labour 
 
Study Control 
Type of labour 
No % No % 
Spontaneous 38 pts 76 % 41 pts  82  
Induced 12 pts  24 %  9 pts  18  
 
 
 
In the study group had 38 patients had spontaneous 
labour and 12 patients had induced labour.  In the 
control group labour was induced in 19 patients and the 
remaining 41 had spontaneous labour. 
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Table 5 
 
Membrane Status 
 
Study Control Membrane 
status No % No % 
 Intact 44  88 40 80 
 Absent 06 12 10 20 
 
 
 
44 patients (88%) had intact membranes at the time 
of admission. In the control group 40 patients (80%) had 
intact membranes. 
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Table 6 
 
Duration of active phase of Ist stage labour 
 
Study (min) Control (min) 
 
Mean SD Mean SD 
Primipara 192.2 24.1 400.4 32.5 
Multipara 154.2 24.1 302.5 44.7 
Total 174.2 36 357.3 62 
“P”Value 0.0001 
 
In the study group the duration of First stage of 
labour ranged from 2hrs 5min to 4hrs20 min in 
primigravidas and from1hrs20min to 3hrs30 min in 
multiparas.  In the control group First stage of labour 
ranged from 4hrs2min to 7hrs40 min in primiparous 
patients and from 2hrs20min to 6hrs05 min in 
multiparas. 
 
 
The mean of active duration of first stage of labour 
were lower for the study cases (174.2) then the control 
cases (357.3 min) and this difference is statistically 
significant. 
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Table 7 
 
Rate of cervical dilatation (cms /hr) 
 
Study (cms/hr) 
Control 
(cms/hr)  
Mean SD Mean SD 
Primipara 2.2 0.4 1.1 0.3 
Multipara 2.8 0.5 1.4 0.1 
Total 2.5 0.5 1.2 0.3 
“P”Value 0.0001 
 
 
 The rate of cervical dilatation were lower for primi 
paras than multiparas in both groups. The differences 
were also statistically significant. 
 
 The mean rate of cervical dilatation for the study 
groups was 2.5 cms / hr and this is significantly higher 
than the mean rate of cervical dilatation for the control 
cases (1.2 cms / hr.) 
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Rate of cervical dilatation (cms /hr) 
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Table 8 
 
2ND STAGE DURATION 
 
Study (min) Control (min) 
 
Mean SD Mean SD 
Primipara 29.5 10 30.1 9.7 
Multipara 18.5 7.6 26.2 13.3 
Total 24.0 10.6 28.2 11.8 
“P”Value 0.0001 0.5356 
“P”Value 0.1845 
 
 Among the study cases, there is statistically 
significant difference between the mean duration of 2nd 
stage of labour among primi paras and multiparas. But 
this difference is not significant among the control cases. 
 
 There is no statistical significant difference between 
the mean duration of second stage of labour between 
that of the study group and control group. 
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2ND STAGE DURATION 
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Table 9 
 
Mode of delivery 
 
 
 
Study  Control  
 
No % Mean SD 
Labour 
Natural  
38 96 36 92 
Outlet 
forceps 
2 4 4 8 
LSCS 0 0 0 0 
 
 
In the study group only two patients (4%) required 
assisted vaginal delivery, whereas in the control group 
four patients (8%) were delivered by outlet forceps.   
 
The indication for assisted vaginal delivery in the 
control group was fetal distress in three of the cases and 
prolonged second stage in one patient.  In the study 
group second stage was cut short by outlet forceps for 
prolonged second stage in the case of one patient and 
fetal distress in one patient.  
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Table 10 
 
3RD STAGE DURATION 
 
Study (min) Control (min) 
 
Mean SD Mean SD 
Primipara 6.4 2.7 10.4 3 
Multipara 5.1 2.4 8.2 2.2 
Total 5.8 2.6 9.4 2.9 
“P”Value 0.0001 
 
 The mean duration of 3rd stage of labour is 
significantly higher for primi paras than multiparas. 
 
 There is statistically significant difference between 
the mean duration of 3rd stage of labour between the 
study cases (5.8 minutes) and the control cases (9.4 
minutes.) 
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Table 11 
 
APGAR SCORE 
 
APGAR 1 MIN APGAR 5 MIN 
 
MEAN SD MEAN SD 
 Study 7.7 0.9 8.9 0.6 
 Control 7.9 0.8 8.9 0.8 
     ‘p’ 0.1576 0.7699 
 
 There is no significant difference in the Apgar scores 
of the two groups both at 1 minute and 5 minutes. 
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Table 12 
Average Data 
 
 
Apgar  
 1st Stage 
Duration 
(min)  
Cervical 
Dilatation 
(cms/hr) 
2nd  Stage 
Duration 
(min) 
3rd  Stage 
Duration 
(min) 
Total 
Duration 
(min) 1’ 5’ 
Study 
 
174.2 2.5 24.0 5.8 204.0 7.7 8.9 
Control 357.3 1.2 28.2 9.4 394.9 7.9 8.9 
 
 
The total duration of labour in study group is much 
reduced (mean duration = 204.0 min) when compared to 
that of the control group (mean duration = 394.9 min). 
There is significant reduction of duration of 1st stage and 
3rd stage of labour in the study group when compared to 
that of the control group. There is no significant 
difference of Apgar scores in both groups. 
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Table 13 
 
QUALITY OF PAIN RELIEF 
 
Study group Quality Of Pain 
Relief No % 
Excellent 19 38 
Moderate 14 28 
Mild 14 28 
Nil 3 6 
 
 Among the study cases, 94% had pain relief. Out of 
them, 38% reported excellent pain relief and 28% 
reported moderate pain relief. 
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QUALITY OF PAIN RELIEF 
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Table 14 
 
Maternal morbidity and side effects 
 
Maternal morbidity 
and side effects 
No % 
Tachycardia 15 30 
Drowsy 5 10 
Nausea/vomiting 4 8 
Hallucination 1 2 
Amnesia 4 8 
Nil 21 42 
Total 50 100 
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Table 15 
Impact of giving Ketamine 
 
Ketamine was given to those patients who complained of 
unbearable pain close to delivery. 
 
Ketamine 
Given 
(n=23) 
Not Given 
(n=27) 
 
Mean S.D. Mean S.D. 
‘p’ 
A. Apgar 1” 7.7 1.0 7.7 0.8 0.9918 
B. Apgar 5” 9.0 0.7 8.7 0.5 0.1547 
C. Degree of Pain 
relief 
i) Excellent 
ii) Mild 
iii) Moderate  
iv) Nil 
 
 
14 
3 
6 
- 
 
 
60.9 
13.0 
26.1 
0.0 
 
 
5 
11 
8 
3 
 
 
18.5 
40.7 
29.7 
11.1 
 
 
 
 
0.2396 
 
D. Side Effects 
i) Yes 
ii) No 
 
14 
9 
 
60.9 
39.1 
 
14 
13 
 
51.9 
48.1 
 
0.723 
 
E. NICU Observation 
i) Yes 
ii) No 
 
1 
22 
 
4.3 
95.7 
 
2 
25 
 
 
7.4 
92.6 
 
0.5611 
 
 
It was noted that there were no adverse effects 
following ketamine administration on the Apgar Scores. 
61% of the mothers given ketamine reported excellent 
pain relief. 
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DISCUSSION 
 
A short labour with effect pain relief and minimal 
side effects to mother and fetus is what every labouring 
mother and obstetrician would desire for.  
 
Concept of programmed labour has been introduced 
by Dr. Daftary in 1992. Chauhan et al (2003) and 
Diwakar et al (2002) endorsed these findings.The 
observation that analgesia in labour shortens its duration 
and improves obstetric outcome has been documented in 
various studies, Ganla et al (2000) and Singh et al 
(2000).  
  
Programmed labour utilizes a variety of drugs in 
minimal sub anesthetic doses with the objective of 
providing pain free short labour while at the same time 
decreasing significantly morbidity to mother and fetus. 
 
The aim of present study was to determine the 
influence of the programmed labour protocol on the 
events of labour and obstetric outcome. 
 
Utilizing the principle of drugs synergism the 
individual drug dosage is limited so that each drug is well 
within safety limits so as to avoid maternal and fetal 
jeopardy.  Benzodiazepines (Diazepam) potentiates the 
effect of opioids (Tramadol, Pentazocine) and decreases 
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opioids requirement often in a synergistic (supra 
additive) fashion.   
 
 
The partogram has been used to monitor of the 
progress of labour. The partogram is an excellent 
modality of documenting labour events, Friedman E 
(1954), Daftary (1979), Studd (1973). The integration of 
the partogram in the protocol of programmed labour 
renders its implementation easy and meaningful.  
 
Duration of first stage of labour 
The most common cause of prolonged first stage of 
labour cervical spasm leading to cervical dystocia. A 
tense woman results in a tense cervix.  Pain relief during 
labour provides a break in the pain anxiety vicious cycle 
and accelerates cervical dilatation.  The use of Hyoscine 
and effective spasmolytic  aids in the same and also 
improves co-ordination of uterine contractions. This has 
been widely studied and documented, Desai et al (1984), 
Geseck E (1952), Khosla et al (2003), Mehrotra A (2001), 
Mishra et al (2002), Puri et al (1988), Ranka et al 
(2002), Sarin et al (1982), and Sharma et al (2003). 
Since then many others have evaluated it with success. 
The duration of the first stage labour was significantly 
reduced and rate of cervical dilatation was doubled with 
the programmed labour protocol. 
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Duration of Second Stage of Labour 
The mean duration of second stage of labour was 
not significantly diofferent in the study group when 
compared the control.  However, labour analgesia 
provided a more favorable environment for the mother 
which entailed better co-operation.  The use of Ketamine 
close to delivery produced profound analgesia and  
anaesthesia.  As Ketamine is used in very small doses 
0.5mg/hr and also because of short half life side effects 
both mother and fetus are minimal.  Two of the patients 
were given top up doses (0.25mg/kg) at half an hour 
interval with no adverse effects.   
 
Duration of Third Stage of Labour 
The third stage of labour was actively managed by 
administering 0.4mg methergine iv at the time of 
delivery of the anterior shoulder.  The mean duration of 
third stage as well as the amount of blood loss was 
significantly reduced in the study group (mean 5.8 min) 
when compared to the control (mean 9.4 min). 
 
Effect on Fetus 
The well being of the new born was unaltered by 
programmed labour as evidenced by identical APGAR 
scores in both the study and control group.  The mean 
APGAR score in the study group was 7.7 at 1minute and 
8.9 at 5minutes and that the control group was 7.9 at 1 
minute and 8.9 at 5 minutes. The difference was not 
statistically significant.   
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Effect on mother 
The provision of pain free and shorter labour 
ensures that childbirth is a joyous event. 38% reported 
excellent pain relief.  Multigravidas were better able to 
feel the difference and document the extent of pain 
relief, and reported labour as much more satisfying. 8% 
reported amnesia for the events during labour and stated 
the labour as comfortable one. 
 
Adverse effects 
The commonest side effect noted was tachycardia 
(30%).There was no alteration in BP in any of the 
patients administered the drugs in the study group.  
Nausea was reported by two patients (4%).  A significant 
number, 7 patients (14%) reported amnesia for the 
events of labour.  Hallucinations were reported by only 
one patient.  The use of Diazepam and slow 
administration of Ketamine was responsible for the low 
incidents of hallucinations. None of the side effects 
caused anxiety 
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SUMMARY 
 
9  The study was performed on 50 low risk antenatal 
mothers in active labour. 
 
9  The majority of the patients belong to the age group 
of 21-25.  The mean age of the study group was 
23.7 years and the control group was 24 years.70% 
of the study cases were booked and 60% of the 
control cases  were booked. 
 
9  The study group has significantly shorter labour 
when compared to the control.  The mean duration 
of labour was reduced by 50%.   
 
9  The rate cervical dilatation was doubled when 
compared to that of a control group.   
 
9  The mean duration of second stage of labour was 
not significantly different in study group and control 
group. 
 
9  The duration of 3rd stage of labour was significantly 
reduced. 
 
9  The neonatal outcome shown by APGAR score was 
almost the same for both study and control group.   
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9  Quality of pain relief was good with 94 % stating 
that they had some pain relief of which 38 % stated 
that they had excellent pain relief. 
 
9  Need for assisted vaginal delivery was minimal in 
study group 4% vs 8% in control. 
 
9  Fetal distress was 2% in study group when 
compared to 6% in the control.  There were no 
significant fetal side effects following administration 
of drugs for programming of labour. 
 
9  Maternal side effects were minimal and 94% 
reported satisfying labour experience with some 
degree of pain relief. 
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CONCLUSION 
 
 
 
Programmed labour protocol provides good pain relief in 
majority of patients.  It is very safe and has absolutely no major 
complications with minimal minor side effects. 
 
It has a favourable impact on the progress of labour.  It 
augments cervical dilatation and shortens the first stage of labour 
significantly.  Duration of second stage of labour is not affected. It 
reduces the number of assisted vaginal delivery, improves the 
performance, reduces the duration of third stage and incidence of 
postpartum haemorrhage. 
 
There is absolutely no untoward effect on mother and foetus.  
There is no incidence of fetal distress caused by this optimizing 
labour protocol. 
 
To conclude, programmed labour is a safe method which 
shortens the duration of labour facilitates cervical dilatation, 
reduces incidence cervical dystocia, reduces the pain during 
labour, improves maternal and neonatal outcome and decreases 
the need for obstetric intervention. 
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PROFORMA 
 
Name          Case 
No 
Age 
IP No.       Unit 
Booking Status     Married Since 
Gravida :   Para :   Live :  
 Abortion : 
LMP :    Gestational age in weeks : 
EDD : 
Mens Period   Regular / Irregular 
Date & Time of Admission : 
Examination 
Height  PR  BP  RR  
 Temperature 
Weight Anaemia    Pedal oedema : Urine - ALB 
- SUG 
-  
Informed consent       Hb % 
CVS   :       B1. Grouping : 
RS  :       Rh typing 
  
P/A  : 
P/V  : 
 
Nature of Labour 
I) Spontaneous      ARM 
II) Induced       Syntocinon 
 
Bishops Score at time of drug administrations 
 92
Position Length Dilatation Consistency Station 
     
 
Time of administration of drug : 
 
Drug Time 
Diazepam  
Pentazocine  
Tramadol  
Hyoscine  
Ketamine  
 
Duration of first stage : 
Rate of cervical dilatation : 
Duration of second stage : 
 
Mode of delivery 
Labour Natural Instrumental Caesarean Section 
   
 
Indication for instrumental delivery 
 
Pain relief 
Nil  
Mild  
Moderate  
Excellent  
 
Side effects of drugs 
 
Tachycardia  
Rise of BP  
Fall of BP  
Nausea/Vomiting  
Pyrexia  
Hallucinations  
 93
Amnesia  
Post partum haemorrhage  
Vaginal tears/lacerations  
Cervical tears  
Post partum psychosis  
 
Neonatal outcome 
 
Birth wt APGAR Resuscitation NICU 
Obs./Adm. 
 I min 5 min   
     
 
Duration of third stage 
Third stage complications if any : 
Others : 
 94
PARTOGRAM
 
 
 
 95
MASTER CHART 
 
STUDY GROUP 
 
SE
 s
ta
tu
s 
Ed
u 
st
at
us
 
G
es
t 
.a
ge
 
m
ed
ic
al
 c
om
p 
ob
st
. R
is
k 
sp
on
t. 
/in
d 
I s
tg
 
ra
te
 o
f c
er
vi
ca
l 
II 
st
g.
 D
ur
m
in
 
III
 s
tg
. d
ur
.m
in
 
sy
nt
o 
ke
ta
m
in
e 
rp
t. 
ke
ta
m
in
e 
m
od
e 
of
 d
el
. 
In
di
ca
tio
n 
de
go
fp
ai
n 
re
lie
f 
B
ab
y 
W
t. 
A
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ar
 
1"
 
A
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ar
 
5"
 
IV 5th 38 nil nil spont 4hr20m 1.6 32 3 no no 0 LN epi - mod 2.85 8 9 n
IV 8th 41 nil nil ind  4hr 1.8 30 4 yes no 0 LN epi - mod 2.7 7 9 t
1 V 3rd 39 nil nil spont 2hr40m 2.6 20 3 no no 0 LN epi - excellent 3 8 9 n
IV 11th 40 nil nil spont 4hr 1.7 35 5 no no 0 LN epi - mild 3 7 8 n
IV grad 40 nil PROM ind  2hr35m 2.7 30 4 yes given 0 LN epi - excellent 2.9 7 8 dn
1 IV 4th 40 nil nil spont 2hr45m 2.5 20 3 no no 0 LN    - excellent 2.8 7 9 n
1A IV 9th 37 nil PROM spont 2hr 3.5 12 5 no given 0 LN - excellent 2.9 8 9 ho
1 V nil 40 nil nil spont 2hr50m 2.5 25 4 yes given 0 LN epi - mod 3.2 8 8 t
III 12th 41 nil ROP ind  3hr20m 2.1 60 5 no no 0 outlet Pro.2
nd  
Stage mild 3.25 6 8 t
IV 8th 39 nil nil spont 2hr5m 3.3 35 4 yes no 1 LN epi - mod 2.7 8 8 n
1 IV 3rd 40 nil nil spont 2hr30m 2.8 15 4 no no 0 LN - excellent 2.6 9 9 n
IV 8th 38 nil nil spont 3hr 2.3 35 4 no no 0 LN epi - mild 3 7 8 n
IV 11th 41 nil nil ind  3hr10m 2.2 30 5 yes no 0 LN epi - mild 2.8 7 9 t
V nil 40 nil nil spont 3hr 2.3 25 3 yes no 0 LN epi - nil 2.6 8 9 n
IV 11th 39 nil md.7yrs spont 3hr15m 2.1 11 2 yes no 0 LN epi - mod 2.9 8 9 t
IV 6th 37 nil nil spont 3hr 2.3 25 3 yes no 0 LN epi - mild 2.7 8 9 n
2 V 8th 41 nil nil spont 2hr30m 2.8 10 4 no given 0 LN - mod 3.35 9 10 t
IV 12th 38 nil nil spont 2hr40m 2.6 30 4 no given 1 outlet Fetal  distress excellent 3.1 7 9 n
IV 6th 39 nil PROM ind  2hr40m 2.6 25 8 yes no 0 LN epi - nil 2.8 9 9 ts
IV 12th 40 nil Rh-ve ind  3hr 2.3 32 7 yes no 0 LN epi - excellent 3 9 10 d
IV 9th 41 nil nil spont 3hr30m 2 18 6 yes given 0 LN epi - excellent 3.1 7 8 n
IV nil 37 nil nil spont 3hr 2.3 22 8 no given 0 LN epi - excellent 2.6 7 8 d
1 IV 9th 39 nil nil spont 1hr40m 4.2 12 5 no given 0 LN - excellent 2.7 9 10 n
1 V 4th 40 nil nil spont 2hr40m 2.6 14 5 no no 0 LN - mod 2.65 8 9 t
IV 8th 40 nil nil spont 3hr10m 2.2 25 12 no given 0 LN epi - mild 3.1 7 9 d
V 3rd 39 nil nil spont 2hrs10m 3.2 16 7 yes given 0 LN - excellent 2.7 9 9 t
1 IV 10th 40 nil nil ind  2hr30m 2.8 30 9 yes given 0 LN lp - excellent 2.9 7 9 n
1 IV 11th 38 nil nil spont 2hr15m 3 15 3 no given 0 LN - excellent 3 9 9 n
IV 5th 41 nil nil spont 3hr 2.3 40 10 yes no 0 LN epi - mild 3.1 7 8 n
1 III grad 40 nil nil spont 3hr 2.3 25 6 yes no 0 LN epi - mod 3 7 8 n
IV 12th 41 nil nil ind  3hr10m 2.2 30 9 yes given 0 LN epi - mod 2.8 6 9 dn
V nil 39 nil nil spont 4hr 1.8 30 15 no no 0 LN epi - mild 2.9 8 9 n
1 IV 3rd 37 nil nil spont 2hr30m 2.8 10 3 yes given 0 LN - excellent 2.75 9 10 t
1 IV 8th 38 nil nil spont 2hr20m 3 16 4 no given 0 LN - excellent 3.3 8 9 aa
IV 8th 40 nil nil spont 3hr30m 2 30 7 no no 0 LN - nil 2.8 9 9 n
V nil 40 nil nil spont 2hr20m 3 45 6 yes given 0 LN - mild 2.9 9 9 n
IV 12th 37 nil nil spont 3hr10m 2.2 20 6 no no 0 LN - mild 2.9 8 9 a
IV 5th 41 nil nil spont 3hr30m 2 25 8 yes given 0 LN epi - mild 2.7 9 10 n
2 V 8th 38 nil nil spont 2hr10m 3.5 6 4 yes given 0 LN epi - excellent 2.65 8 10 n
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1A IV 4th 38 nil nil spont 2hr 3.5 16 7 no no 0 LN - mod 2.9 8 9 t
IV 7th 39 nil nil spont 3hr30m 2 35 9 yes no 0 LN epi - mild 3.3 8 9 n
IV 10th 40 nil nil spont 2hr30m 2.8 35 7 yes given 0 LN epi - excellent 3.2 7 8 n
V 10th 41 nil nil ind  3hr30m 2 22 7 no no 0 LN epi - mod 3 7 9 n
1 III 6th 40 nil Rh-ve ind  2hr20m 3 30 8 yes no 0 LN epi - excellent 3.2 7 8 t
1 IV 5th 37 nil nil spont 2hr40m 2.6 11 4 no no 0 LN - mild 2.8 7 9 n
2 IV nil 39 nil nil spont 3hr 2.3 8 3 no given 0 LN - excellent 2.85 7 9 t
V grad 40 nil nil ind  3hr 2.3 40 9 yes given 0 LN epi - mod 3.2 6 9 d
V 8th 37 nil nil spont 3hr30m 2 25 7 no no 0 LN epi - mild 3 7 8 d
IV 9th 38 nil nil spont 4hr 1.8 20 7 no given 0 LN epi - mod 3 7 9 t
1 V 3rd 40 nil nil ind  2hr15 3.1 20 5 yes given 0 LN epi - mod 3.1 7 9 te
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1 primi IV 5 37 nil nil  6hrs 20 1.1 40 10 yes LN epi  - 2.9 7
1 primi V 8 39 nil nil s 6hr25 1.1 30 15  LN epi  - 3.0 8
9 primi IV 5 40 nil nil s 7hr 1 15 12  LN epi  - 2.75 8
2 primi V 6 41 nil nil s 7hr40min 0.9 35 8  LN epi  - 2.8 9
9 primi V 11 40 nil nil s 6hr40m 1 70 6  outlet Pro.2nd stg 2.9 8
5 primi IV 7 39 nil nil s 7hr 1 40 9  LN epi  - 3.0 7
6 primi IV 9 38 nil nil I 6hr30m 1 25 10 yes LN epi  - 3.1 7
1 primi IV 12 37 nil nil s 6hr20m 0.9 30 12  LN epi  - 2.8 8
1 primi V 11 39 nil nil s 7hr20m 1 35 14  LN epi  - 2.6 9
0 primi IV 9 40 nil nil s 7hr25 1 40 9  LN epi  - 2.9 8
9 primi IV 7 41 nil nil i 7hr 1 15 9  LN epi  - 2.85 8
2 primi IV 8 40 nil nil s 6hr30m 1.1 20 10 yes LN epi  - 2.7 8
3 primi IV 9 37 nil nil s 6hr 40m 1.1 30 16  LN epi  - 2.7 7
2 primi IV 10 38 nil nil i 6hr 50m 1 50 12  LN epi  - 3.0 8
5 primi III g 39 nil nil s 6hr45m 1 35 15 yes LN epi  - 2.8 9
4 primi III g 40 nil nil s 6hr40m 1 20 12  LN epi  - 3.1 9
5 primi IV 12 37 nil nil s 6hr35m 1.1 40 8  LN epi  - 3.1 7
7 primi IV 9 38 nil nil s 6hr10m 1.2 20 6 yes LN epi  - 2.75 8
8 primi IV 4 41 nil nil s 6hr50m 1 15 8 yes LN epi  - 2.6 7
9 primi V 4 40 nil nil i 6hr50m 1 18 9  LN epi  - 2.5 8
9 primi IV 5 40 nil nil s 7hr 1 20 11  LN epi  - 3.1 8
0 primi V 11 38 nil nil s 6hr 1.2 15 10  LN epi  - 2.8 9
0 primi V 20 39 nil nil s 7hr10m 1 50 5 yes outlet fet.distress 2.7 7
1 primi IV 8 39 nil nil i 6hr30m 1.2 22 11  LN epi  - 2.6 7
5 primi IV 9 38 nil nil s 7hr40m 0.9 35 7  outlet - 2.85 8
4 primi V 7 39 nil nil s 5hr30m 1.3 20 14  LN epi  - 2.8 9
6 primi IV 8 41 nil nil s 5hr40m 1.2 25 15 yes LN epi  - 2.6 7
2 primi III 4 39 nil nil s 5hr50m 1.1 15 8  LN epi  - 3.0 8
7 G2P1L1 IV 11 40 nil nil s 5hr30m 1.3 20 6  LN epi  - 3.2 9
5 G3P2L1 IV 10 40 nil nil s 5hr30m 1.3 25 9  LN epi  - 3.0 8
3 G2P1L1 IV 9 41 nil nil s 5hr 1.4 18 10  LN - 3.0 8
4 G2P1L1 V 6 40 nil nil s 5hr10m 1.4 30 12  LN - 2.8 7
6 G2P1L1 IV 7 39 nil nil i 4hr50m 1.4 30 5  LN epi  - 2.9 8
8 G2P1L1 IV 4 37 nil nil i 6hr 1.1 50 8  outlet fe.distress 2.65 7
9 G2P1L1 IV 11 41 nil nil s 6hr 1.1 25 9  LN epi  - 2.75 8
4 G3P2L1 V 4 38 nil nil s 4hr 1.7 20 7  LN epi  - 2.8 8
4 G2P1L1 III 5 39 nil nil s 5hr20 1.3 20 9  LN - 2.7 7
5 G3P1L1A1 IV 9 41 nil nil s 5hr20 1.3 35 4  LN epi - 2.6 8
3 G2P1L1 V 10 40 nil nil s 4hr30 1.5 20 8  LN epi - 2.9 7
5 G3P1L1A1 IV 8 40 nil nil s 4hr40m 1.4 35 10  LN epi - 3.0 9
2 G2P1L1 IV 9 39 nil nil s 5hr10m 1.4 16 9  LN - 3.1 9
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0 G3P2L2 IV 8 40 nil nil i 5hr 1.4 34 5  LN epi - 2.9 9
9 G2P1L1 V 4 38 nil nil s 5hr30m 1.3 28 8  LN - 2.8 8
5 G3P2L2 IV 9 39 nil nil s 5hr40m 1.2 34 9  LN epi - 3.0 8
7 G2P1L1 V 4 40 nil nil s 5hr10m 1.4 22 11 yes LN epi - 2.5 7
6 G3P2L2 IV 7 40 nil nil s 4hr40m 1.5 25 5  LN - 2.6 9
0 G2P1L1 III 6 41 nil nil s 6hr 1.2 30 11  LN epi - 3.0 9
7 G3P2L2 IV 5 37 nil nil s 3hr10m 2.2 12 9  LN - 2.6 7
6 G3P1L1A1 V 5 39 nil nil i 3hr30m 2 8 10  LN epi - 2.6 8
1 G2P1L1 III 9 40 nil nil s 5hr15m 1.4 40 6  outlet fe.distress 3.3 7
 
 
 
 
